Market Research Report
Germany Neurorehabilitation Device Market Forecast 2021-2026
|Published by||Inkwood Research||Product code||980918|
|Published||Content info||119 Pages
Delivery time: 2-3 business days
|Germany Neurorehabilitation Device Market Forecast 2021-2026|
|Published: January 11, 2021||Content info: 119 Pages||
The Germany neurorehabilitation device market is expected to register a CAGR of 15.69%, during the forecast period. The country's market growth is attributed to factors, such as, the key strategies adopted by several market players and the increasing geriatric population. The base year considered for the market study is 2020, and the forecast years are from 2021 to 2026.
The key strategies adopted by leading players in Germany, including product launches, play a significant role in fueling the neurorehabilitation device market growth. For example, in 2017, the company MindMaze launched its neuro-3D Virtual therapy device, called MindMotion, in order to facilitate recovery after a stroke or brain injury. The portable neurotechnology device uses a 3D virtual environment, primarily for continuing therapy, post brain injury. Moreover, the company's next wave system entails a non-invasive brain stimulator, developed to expand the visual field of patients with numerous neurological ailments. As a result, the adoption of neurorehabilitation devices is likely to observe a growing trend in Germany.
In addition, the growing healthcare expenditure is projected to supplement neurorehabilitation devices' research in the country, thereby influencing the market growth. The population over the age of 60, is more vulnerable to neurological disorders, including Alzheimer's disease, Parkinson's disease, and dementia. Hence, the swift increase in Germany's senior population is also a crucial factor augmenting the demand for neurorehabilitation devices. Therefore, such factors are attributed to the country's market, during the forecast period.
Some of the prominent companies operating in the market are, Ectron Limited, Biometrics Ltd, Hocoma AG, Medtronic Inc, etc.